SkinCheck is a digital health startup dedicated to revolutionizing skin cancer detection and dermatological care access through innovative AI technology. Our platform offers a first-of-its-kind, racially unbiased AI-powered screening tool designed to detect skin cancer accurately across all skin tones. By empowering users with a mobile application for early risk assessment and streamlined teledermatology consultations, SkinCheck bridges the gap between patients and timely medical care. Our business model integrates both B2B and B2C channels, catering to individual users seeking accessible dermatological assessments, as well as health systems and providers aiming to enhance patient care and reduce costs through early detection. With over 130,000 users and partnerships with leading healthcare providers, SkinCheck is poised to transform skin health management globally by improving early detection and reducing healthcare inequities.
XomaHealth, LLC has developed an innovative, patented medical device to remedy Xerostomia (dry mouth), especially at night. This device will improve the quality of life for millions of patients.
Dry mouth causes loss of sleep, decline in dental health, loss of teeth, mouth sores, and other serious health issues. There are NO remedies for millions of people that have the significant medical problem of impaired or no saliva glands or for nighttime relief.
A study estimated 20% of the US population suffers from Xerostomia or approximately 66 million people. This demonstrates a significant market opportunity. XomaGuard will be an OTC product and there are no similar products on the market.
We are a fully packaged and customizable commercial fleet vehicle accident support platform. This means that when, for example, a fleet accident occurs, we align the process for the fleet drivers, fleet managers/companies, and any other party that may be involved. We provide real-time streaming of the accident process (what the fleet driver is doing after the accident) to the fleet company to ensure company protocol is being followed to the T. It is critical that there are no idiosyncrasies in the post-accident process to avoid many costly outcomes with litigation and claims issues being the most costly. We want to make sure that doesn’t happen to your fleet company.
At EnCor Industries, our mission is to enable businesses to scale faster, reduce costs, & retain control over their creations. In the next 2 years, we aim to empower over 50 startups through subsidized prototyping credits, ensuring access to advanced manufacturing. Our short-term objectives include producing more than $500,000 in manufactured parts, establishing 3 strategic partnerships with ESOs & EDOs, & reducing prototyping costs by 80%. Additionally, we are committed to retaining over 15 bioTech & emerging hardTech startups in Oklahoma, strengthening the local innovation ecosystem & fostering a new wave of industrial growth.
Register to attend March 2025 Pitch Lunch
